Education Journal, Vol. 3, Issue 1, Mar  2020, Pages 9-15; DOI: https://doi.org/10.31058/j.edu.2020.31002 https://doi.org/10.31058/j.edu.2020.31002

Role of 3 Atypical Infections (B. Pertussis, C. Pneumonia, M. Pneumonia) in Cases with Prolonged Cough (> 2 weeks): A Cross Sectional Study in Tehran, Iran

, Vol. 3, Issue 1, Mar  2020, Pages 9-15.

DOI: https://doi.org/10.31058/j.edu.2020.31002

Anahita Izadi 1 , Samileh Noorbakhsh 2* , Zahra Movahedi 3 , Sarvenaz Ashouri 4

1 Department Pediatric Infectious Diseases, Tehran University of Medical Sciences, Tehran, Iran

2 Pediatric & Research Center of Pediatric Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran

3 Department Pediatric infectious Diseases, Qom University of Medical Sciences, Qom, Iran

4 ENT and Head and Neck Research Center and Department, Iran University of Medical Sciences, Tehran, Iran

Received: 6 November 2019; Accepted: 15 January 2020; Published: 13 February 2020

Full-Text HTML | Download PDF | Views 72 | Download 43

Abstract

Chronic cough is a worldwide problems caused by both usual and unusual bacteria. In present study we have searched the atypical organisms; Bordetella Pertussis, Clamydia Pneumonia, Mycoplasma Pneumonia in nasopharyngeal secretion of cases with  prolonged  cough (>2weeks) by Real time PCR. In a prospective cross sectional study we selected 170 children with prolonged cough (>2 weeks) and their close contact persons including 45.9% male and 54.1% female with mean age 27.3±23.8 years, during 2008-2010 in Rasoul Akram Hospital  a reffering hospital in Tehran, Iran .We searched DNAs of 3 atypical infection (C. pneumonia , M. Pneumonia ,and B. pertussis)  by Real time PCR in nasopharyngeal secretion of  cases. Fever seen in 50% of cases, 34.3% of cases had contacted with other cases with prolonged cough, abnormal chest x-ray detected in 61.6%. Other symptoms (convulsion, conjunctional hemorrhage …) except the chronic cough reported in 67.6% of cases. C. pneumonia and B. pertussis detected in 4.8% of cases but M. pneumonia DNA had not found in any cases. As conclusion, C. pneumonia and B. pertussis have a minor role (2.4%; 2.4%) in patients with prolonged cough. (>2weeks) .Most positive cases had previous contact, 50% was febrile and had abnormal chest X ray. Direct detection of Chlamydia pneumonia by polymerase chain reaction on nasopharyngeal aspirates is highly correlated with active infection .In the late stages of prolonged cough serological testing may be more beneficial for obtaining a microbiological diagnosis.

Keywords

Chronic Cough, B. pertussis, C. Pneumonia, M. Pneumonia, Real Time- PCR

Copyright

© 2017 by the authors. Licensee International Technology and Science Press Limited. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

[1]He, Q.; Mertsola, J. Factors contributing to pertussis resurgence. Future Microbiol. 2008, 3(3), 329-39.

[2]Pertussis.WHO Immunological Basis for Immunization Series Module 4: 2017; pp. 1-2.

[3]Martinez, G.J.; Chaves, F.; Salto, E.; Otero, J.R. Bordetella pertussis detection by real-time PCR, immunofluorescence and culture: prospective evaluation and molecular epidemiology. Infec Microbiol Clin. 2006, 24(8), 500-4.

[4]Mansoor, G.R.; Karimi, A.; Sadeghi, H.; Esteghamti, A.; Falah, F.; Armin, S.H. et al. Sensitivity and specificity of the World Health Organization pertussis clinical case definition. International Journal of Infectious Diseases, 2010, 14(12), e1072–e1075.

[5]Ko, S.K.; Riffelmann, M.; Wirsing von Ko¨ nig C.H. Evaluation of a real-time PCR assay for detection of Bordetella pertussis and Bordetella parapertussis in clinical samples. J Med Microbiol, 2001, 50, 436-40.

[6]Zarei, S.; et al, Immunogenicity of a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian preschool children. Iran J Immunology, 2007, 4(2), 101-9.

[7]Cherry, J.D.; Tan, T.; Wirsing von König, C.H.; Forsyth, K.D.; Thisyakorn U, et al. Clinical definitions of Pertussis: Summary of a Global Pertussis Initiative Roundtable Meeting, 2011. Clin Infect Dis. 2012, 54(12), 1756-64.

[8]Cagney, M.; McIntyre, P.B.; Heron, L.; Giammanco, A.; MacIntyre, C.R. The relationship between pertussis symptomatology, incidence and serology in adolescents. Vaccine, 2008, 26(44), 5547-53.

[9]Movahedi, M.; Haghdoost, A.A.; Pournik, O.; Hajarizadeh, B.; Fallah, M.S. Temporal variations of health indicators in Iran comparing with other Eastern Mediterranean Region countries in the last two decades. J Public Health, 2008, 30(4), 499-504.

[10]Zahraei, S.M.; Doosti, F. Distribution of pertussis in Iran in 2007. The 17th Iranian congress on Infectious dis¬eases and tropical medicine. Tehran, Iran. 2008; pp. 129.

[11]Sherkat, R.; Salehy, H.; Yazdani, R. The assessment of the Bordetella pertussis in adults with cough ≥ 6 weeks. The 14th Iranian Congress on Infectious Diseases and Tropical Medicine, 2005, 216, 27.

[12]Hashemi, S.H.; Ranjbar, M.; Hajilooi, M.; Seif-Rabiei, M.A.; Bolandi, M.; Moghimi, J. Seroprevalence of Immu¬noglobulin G antibodies against pertussis toxin among asymptomatic medical students in the west of Iran: a cross sectional study. BMC Infect Dis, 2009, 9(9), 58.

[13]Eslamifar, A.; Ramezani, M.; Banifazl, A.; Khadem-Sadegh. A Aghakhani,Seroprevalence of IgG Antibodies against Bordetella pertussis in Different Age Groups in Tehran, Iran. Iranian Journal of Pathology, 2012, 7(3), 171-176.

[14]Bamberger, E.; Lahat, N.; Gershtein, V.; Gershtein, R.; Benilevi, D.; Shapiro, S.; et al. Diagnosing pertussis: the role of polymerase chain reaction. Isr Med Assoc J. 2005, 7, 351-4.

[15]Diez-Domingo, J.; Ballester, A.; Baldo, J.M.; Planelles, M.V.; Villarroya, J.V.; Alvarez T.; et al. Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents, and adults. J Infect. 2004, 49(3), 242-7.

[16]Garcia-Corbeira P, Dal-Re R, Aguilar L, Garcia-de-Lomas J. Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study. Vaccine 2000, 18(21):2173-6.

[17]Wilder-Smith A.; Ng, S.; Earnest, A. Seroepidemiology of pertussis in the adult population of Singapore. Ann Acad Med Singapore, 2006, 35(11), 780-2.

[18]Strebel P.; Nordin J.; Edwards K.; Hunt J.; Besser J.; Burns S, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995–1996. J Infect Dis. 2001, 183, 1353-9.